MedyMatch to Demonstrate New Clinical Decision Support Platform for Detecting Intracranial Hemorrhage in Acute Care at RSNA 2017

CHICAGO, Nov. 26, 2017 /PRNewswire/ --

Who:
MedyMatch CEO Gene Saragnese and the MedyMatch team.

What:
Demonstrations: MedyMatch Technology, a leading artificial intelligence company delivering real-time clinical decision support in acute medical scenarios, will demonstrate deep learning algorithms for the acute care marketplace at RSNA 2017. MedyMatch's technology is designed to work within the existing workflow to augment clinicians in their assessment of patients suspected of acute head trauma or stroke, where intracranial hemorrhage may be present.¹

Announcement: MedyMatch will also be making a major announcement at RSNA 2017.

When:
Sunday, November 26 through Thursday, November 30, 2017 at the Radiological Society of North America (RSNA) Annual Meeting in Chicago, Illinois.

Where:
The demonstrations will take place inside the booths of MedyMatch's partners - IBM Booth #3337, Samsung Healthcare Booth #2543 and at the Machine Learning Showcase Booth #8149 during RSNA 2017 at McCormick Place in Chicago.

Why:
"As the amount of imaging data to interpret has increased exponentially, radiologists have come under intense pressure to read more cases in less time which is reducing their quality of life as they struggle to be accurate, confident and very, very fast," Dr. Ajay Choudhri, Chairman and Medical Director, Department of Radiology, Capital Health Hospital.  "The ability to prioritize challenging cases, such as a brain hemorrhage, within the existing workflow, benefits both the acute patient as well as collaborating clinicians."

Contact:
Michael Rosenberg, [email protected]

¹ Pending regulatory approvals.  In the US, limited by Federal Law to investigational use.

SOURCE MedyMatch Technology